
Robert C. Boyle
Examiner (ID: 9565, Phone: (571)270-7347 , Office: P/1764 )
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1764, 1796 |
| Total Applications | 1334 |
| Issued Applications | 896 |
| Pending Applications | 89 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5850687
[patent_doc_number] => 20060233878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Extended release formulation of beta-lactam antibiotics'
[patent_app_type] => utility
[patent_app_number] => 10/568325
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4237
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568325
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568325 | Extended release formulation of beta-lactam antibiotics | Sep 29, 2003 | Abandoned |
Array
(
[id] => 5894467
[patent_doc_number] => 20060003006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Controlled delivery system for bioactive substances'
[patent_app_type] => utility
[patent_app_number] => 10/529537
[patent_app_country] => US
[patent_app_date] => 2003-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9261
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529537 | Controlled delivery system for bioactive substances | Sep 23, 2003 | Abandoned |
Array
(
[id] => 5726425
[patent_doc_number] => 20060057185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person'
[patent_app_type] => utility
[patent_app_number] => 10/529014
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8628
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529014 | Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person | Sep 21, 2003 | Abandoned |
Array
(
[id] => 5743681
[patent_doc_number] => 20060089406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases'
[patent_app_type] => utility
[patent_app_number] => 10/528308
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10011
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10528308
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528308 | Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases | Sep 17, 2003 | Issued |
Array
(
[id] => 5776289
[patent_doc_number] => 20060104929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Aqueous emulsion comprising an organosilicon polymer, process for producing the same and cosmetic materials'
[patent_app_type] => utility
[patent_app_number] => 10/526184
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11343
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526184 | Aqueous emulsion comprising an organosilicon polymer, process for producing the same and cosmetic materials | Sep 11, 2003 | Abandoned |
Array
(
[id] => 5784485
[patent_doc_number] => 20060204576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers'
[patent_app_type] => utility
[patent_app_number] => 10/532831
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7943
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532831 | Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers | Sep 3, 2003 | Abandoned |
Array
(
[id] => 7398689
[patent_doc_number] => 20040039057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Topical analgesic compositions containing aliphatic polyamines and methods of using same'
[patent_app_type] => new
[patent_app_number] => 10/380675
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5029
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380675 | Topical analgesic compositions containing aliphatic polyamines and methods of using same | Aug 27, 2003 | Abandoned |
Array
(
[id] => 5866083
[patent_doc_number] => 20060100214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Fast dissolving and taste masked oral dosage form comprising sildenafil'
[patent_app_type] => utility
[patent_app_number] => 10/525680
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5844
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525680 | Fast dissolving and taste masked oral dosage form comprising sildenafil | Aug 19, 2003 | Abandoned |
Array
(
[id] => 7234352
[patent_doc_number] => 20050256178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Novel nutraceutical compositions comprising boitin'
[patent_app_type] => utility
[patent_app_number] => 10/525348
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525348
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525348 | Novel nutraceutical compositions comprising boitin | Aug 17, 2003 | Abandoned |
Array
(
[id] => 5859799
[patent_doc_number] => 20060229258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Steroidal compositions containing hydroxycarboxylic acids and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/566079
[patent_app_country] => US
[patent_app_date] => 2003-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9465
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229258.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566079 | Steroidal compositions containing hydroxycarboxylic acids and methods of using the same | Jul 29, 2003 | Abandoned |
Array
(
[id] => 5865191
[patent_doc_number] => 20060099321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Cereal based food product comprising dha and/or epa'
[patent_app_type] => utility
[patent_app_number] => 10/523765
[patent_app_country] => US
[patent_app_date] => 2003-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4059
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099321.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523765 | Cereal based food product comprising dha and/or epa | Jul 28, 2003 | Abandoned |
Array
(
[id] => 6959233
[patent_doc_number] => 20050215487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Conjugates comprising an nsaid and a sugar and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/518618
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6668
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518618 | Conjugates comprising an nsaid and a sugar and uses thereof | Jun 26, 2003 | Abandoned |
Array
(
[id] => 7233043
[patent_doc_number] => 20050256061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Use of isoflavones for preparing topical compositions for promoting slimming, and related cosmetic treatment method'
[patent_app_type] => utility
[patent_app_number] => 10/519096
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4372
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256061.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519096 | Use of isoflavones for preparing topical compositions for promoting slimming, and related cosmetic treatment method | Jun 24, 2003 | Abandoned |
Array
(
[id] => 7422597
[patent_doc_number] => 20040265249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Composition for protecting skin from damaging effects of ultraviolet light'
[patent_app_type] => new
[patent_app_number] => 10/602188
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6452
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602188 | Composition for protecting skin from damaging effects of ultraviolet light | Jun 23, 2003 | Abandoned |
Array
(
[id] => 6982860
[patent_doc_number] => 20050152930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use'
[patent_app_type] => utility
[patent_app_number] => 10/515219
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4772
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515219 | Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use | May 22, 2003 | Abandoned |
Array
(
[id] => 4733446
[patent_doc_number] => 20080050425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex'
[patent_app_type] => utility
[patent_app_number] => 10/557671
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16156
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557671 | Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex | May 19, 2003 | Abandoned |
Array
(
[id] => 7440855
[patent_doc_number] => 20040195549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Lipid-soluble formulations containing mixtures of antioxidants'
[patent_app_type] => new
[patent_app_number] => 10/407285
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4411
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20040195549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407285 | Lipid-soluble formulations containing mixtures of antioxidants | Apr 3, 2003 | Abandoned |
Array
(
[id] => 6850962
[patent_doc_number] => 20030143165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'NSAID-containing topical formulations that demonstrate chemopreventive activity'
[patent_app_type] => new
[patent_app_number] => 10/310824
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6815
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10310824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/310824 | NSAID-containing topical formulations that demonstrate chemopreventive activity | Dec 5, 2002 | Abandoned |
Array
(
[id] => 7372362
[patent_doc_number] => 20040219201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Tempamine compositions and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/314487
[patent_app_country] => US
[patent_app_date] => 2002-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12889
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314487 | Tempamine compositions and methods of use | Dec 4, 2002 | Abandoned |
Array
(
[id] => 6842603
[patent_doc_number] => 20030147950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Modified release tamsulosin tablets'
[patent_app_type] => new
[patent_app_number] => 10/289385
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6215
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10289385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/289385 | Modified release tamsulosin tablets | Nov 6, 2002 | Abandoned |